Accendra Health (ACH) Net Income towards Common Stockholders (2009 - 2025)

Accendra Health (ACH) has 16 years of Net Income towards Common Stockholders data on file, last reported at -$46.9 million in Q4 2025.

• On a quarterly basis, Net Income towards Common Stockholders fell 231.16% year-over-year to -$46.9 million in Q4 2025; TTM through Mar 2026 was -$976.8 million, a 3865.85% decrease from a year earlier, with the FY2025 full-year figure at -$998.0 million, down 8250.43% from the prior year.
• Net Income towards Common Stockholders for Q4 2025 stood at -$46.9 million, up from -$144.7 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for ACH reached as high as $57.5 million in Q4 2023 and fell as low as -$785.2 million in Q2 2025.
• Historically, Net Income towards Common Stockholders has averaged -$62.7 million across 4 years, with a median of -$21.5 million in 2024.
• Across the five-year window, Net Income towards Common Stockholders jumped 199.16% in 2023 and plunged 3019.61% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$58.0 million in 2022, then soared by 199.16% to $57.5 million in 2023, then tumbled by 37.84% to $35.7 million in 2024, then tumbled by 231.16% to -$46.9 million in 2025.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$46.9 million in Q4 2025, -$144.7 million in Q3 2025, and -$785.2 million in Q2 2025.